Latest Conference Articles

ASCRS 2021 going live

ASCRS 2021 going live

June 17th 2021

ASCRS

The event, being held at the Mandalay Bay Resort and Casino in Las Vegas, is offering a full agenda for in-person attendees.

Oculis announces positive data from phase 2 trials with novel topical TNF alpha antagonist OCS-02 for DED, acute anterior uveitis

Oculis announces positive data from phase 2 trials with novel topical TNF alpha antagonist OCS-02 for DED, acute anterior uveitis

May 11th 2021

ARVO

Oculis reported positive data from two of its clinical proof-of-concept phase 2 trials for OCS-02, a novel topical anti-TNF alpha antibody fragment candidate, for the treatment of dry eye disease and acute anterior uveitis.

Gene therapy prompts foveal morphologic changes in LCA

Gene therapy prompts foveal morphologic changes in LCA

May 10th 2021

ARVO

Friederike Kortuem, MD, MSc, discusses how treatment with voretigene neparvovec-rzyl led to a short-term change in the foveal morphology in a patient with visual impairment that included nyctalopia and decreased visual acuity in early childhood.

Analyzing 24-month data of the PALADIN study

Analyzing 24-month data of the PALADIN study

May 7th 2021

ARVO

Michael A. Singer, MD, speaks on the highlights of his presentation focusing on IOP in the PALADIN 24-month data intravitreal steroid (ILUVIEN).

Measuring visual fields with a cloud-based AI platform

Measuring visual fields with a cloud-based AI platform

May 7th 2021

ARVO

Mohamed Abou Shousha, MD, PhD, and Richard Parrish II, MD, discuss their ARVO 2021 presentation regarding a study analyzing visual field measurements using the Heru Visual Field Multi-platform application downloaded on two different commercially available augmented reality devices.

Repository corticotropin injections: Relief for refractory severe noninfectious keratitis

Repository corticotropin injections: Relief for refractory severe noninfectious keratitis

May 7th 2021

ARVO

Joseph Grieco, PhD, notes that treatment fills a gap for patients who are unresponsive to the standard treatments for noninfectious keratitis.

Looking at real-world trial data replication outcomes of IRIS Registry data

Looking at real-world trial data replication outcomes of IRIS Registry data

May 6th 2021

ARVO

Theodore Leng, MD, discusses the highlights from his presentation on "AAO IRIS Registry Data Replicates VIEW 1 and VIEW 2 Clinical Trial Outcome Data," during the virtual 2021 ARVO meeting.

Linking patient imaging data to AAO IRIS Registry

Linking patient imaging data to AAO IRIS Registry

May 6th 2021

ARVO

Michael Mbagwu, MD, speaks on the highlights of his virtual 2021 ARVO presentation regarding the development of an algorithm tool that links patient imaging to their clinical data, specifically within the AAO IRIS Registry.

Clinical results study dexamethasone implant effect on macular thickness

Clinical results study dexamethasone implant effect on macular thickness

May 5th 2021

ARVO

Daniel F. Kiernan, MD, discusses key findings of a clinical study analyzing the effect of dexamethasone intracameral drug-delivery suspension on macular thickness based on OCT testing following vitreoretinal surgery.

Diabetes and DR: Progress in the global epidemic

Diabetes and DR: Progress in the global epidemic

May 5th 2021

ARVO

According to Lloyd Paul Aiello, MD, PhD, a key hurdle for diabetic retinopathy is the lack of patient awareness, which is a substantial contributor to non-adherence to eye care guidelines and poor outcomes.